Quince Therapeutics, Inc. - QNCX
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 22
Latest filed: Apr 09, 2026
| Form | Count |
|---|---|
| 4 | 11 |
| 8-K | 7 |
| SCHEDULE 13G/A | 2 |
| SCHEDULE 13G | 1 |
| 144 | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Apr 09, 2026 | 8-K | Apr 09, 2026 | 0001193125-26-149021 | View |
| Mar 30, 2026 | 8-K | Mar 27, 2026 | 0001193125-26-130489 | View |
| Mar 20, 2026 | 8-K | Mar 16, 2026 | 0001193125-26-117794 | View |
| Mar 05, 2026 | SCHEDULE 13G | — | 0000932540-26-000004 | View |
| Feb 12, 2026 | 8-K | Feb 12, 2026 | 0001193125-26-047544 | View |
| Feb 02, 2026 | 8-K | Jan 30, 2026 | 0001193125-26-033758 | View |
| Jan 29, 2026 | 8-K | Jan 29, 2026 | 0001193125-26-029524 | View |
| Jan 23, 2026 | 4 | Jan 23, 2026 | 0000912282-26-000119 | View |
| Jan 23, 2026 | 4 | Jan 23, 2026 | 0000912282-26-000120 | View |
| Jan 23, 2026 | 4 | Jan 23, 2026 | 0000912282-26-000121 | View |
| Jan 21, 2026 | 4 | Jan 02, 2026 | 0000912282-26-000083 | View |
| Jan 21, 2026 | 4 | Jan 02, 2026 | 0000912282-26-000085 | View |
| Jan 21, 2026 | 4 | Jan 02, 2026 | 0000912282-26-000087 | View |
| Jan 21, 2026 | 4 | Jan 02, 2026 | 0000912282-26-000089 | View |
| Dec 29, 2025 | 4 | Oct 23, 2024 | 0000912282-25-001468 | View |
| Dec 29, 2025 | 4 | Dec 26, 2025 | 0000912282-25-001469 | View |
| Dec 29, 2025 | 144 | — | 0001628280-25-059050 | View |
| Dec 12, 2025 | 4 | Dec 10, 2025 | 0000912282-25-001407 | View |
| Dec 08, 2025 | 4 | Dec 05, 2025 | 0000912282-25-001370 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | — | 0001104659-25-112623 | View |
| Nov 12, 2025 | 8-K | Nov 12, 2025 | 0001193125-25-277523 | View |
| Oct 30, 2025 | SCHEDULE 13G/A | — | 0001140361-25-039832 | View |